SEC Filing Summary: pSivida Limited (Form 6-K)
Business Context and Reporting Period
This Form 6-K was filed by pSivida Limited, a foreign issuer, for the month of October 2005. The report was signed on October 7, 2005, by Aaron Finlay, Chief Financial Officer and Company Secretary. The registrant files annual reports under Form 20-F.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report serves as a notification of a specific regulatory event rather than a financial statement.
Material Changes and Unusual Items
The primary material event disclosed in this filing is the approval of the company's product, RetisertTM, for a US Medicare rebate. This is detailed in Exhibit 99.1 attached to the report.
Guidance, Outlook, and Risks
The filing text does not provide specific guidance, outlook, management commentary, or a discussion of risks and contingencies beyond the notification of the Medicare rebate approval.
Key Facts for Investor Verification
- Verify the effective date and scope of the US Medicare rebate approval for RetisertTM.
- Confirm the potential financial impact of the Medicare rebate on future revenue streams.
- Review the full text of Exhibit 99.1 for specific terms of the approval.